IP Library › Assignment 059726/0788
Patent Assignment
Reel/Frame 059726/0788

Security Interest

Recorded: 2022-04-19 Pages: 25
Assignor
BIOXCEL THERAPEUTICS, INC.
Executed: 2022-04-19
Assignee
OAKTREE FUND ADMINISTRATION, LLC
333 S. GRAND AVENUE, 28TH FL., LOS ANGELES, CALIFORNIA, 90071
Covered Properties (49)
Prevention or treatment of sleep disorders using dexmedetomidine sublingual formulation
Application: 62/064,205 →
Prevention or Treatment of Sleep Disorders Using Dexmedetomidine Formulation
Application: 15/519,463 →
Publication: US 2017/0239221
Use of sublingual Dexmedetomidine for treatment of agitation
Application: 62/471,393 →
Method of Treating Agitation Using Dexmedetomidine
Application: 62/441,164 →
Use of Dexmedetomidine for Treatment of Agitation and Aggression
Application: 62/542,323 →
Use of Sublingual Dexmedetomidine for the Treatment of Agitation
Application: 16/474,882 →
Publication: US 2019/0365715
Use of Sublingual Dexmedetomidine for the Treatment of Agitation
Application: 17/496,470 →
Publication: US 2022/0031663
Thin Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 62/690,407 →
Thin Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 62/693,726 →
Intravenous Administration of Dexmedetomidine to Treat Agitation and Induce a Mild Sedative Effect
Application: 62/767,422 →
Intravenous Administration of Dexmedetomidine to Treat Agitation and Induce a Mild Sedative Effect
Application: 62/787,649 →
Intravenous Administration of Dexmedetomidine to Treat Agitation or Hyper-Arousal
Application: 62/798,842 →
Thin Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 62/849,747 →
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 16/453,679 →
Publication: US 2020/0000717
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 16/931,630 →
Publication: US 2020/0345635
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 17/103,013 →
Publication: US 2021/0077388
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 17/560,392 →
Publication: US 2022/0110864
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 17/560,423 →
Publication: US 2022/0160629
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 17/579,914 →
Publication: US 2022/0142918
Prevention of Emergence of Agitation
Application: 62/901,955 →
Prevention of Emergence of Agitation
Application: 62/976,685 →
Systems and Methods of Using Machine Learning to Detect and Predict Emergence of Agitation Based on Sympathetic Nervous System Activities
Application: 17/698,407 →
Publication: US 2022/0202373
Methods for Treating Agitation Using Dexmedetomidine Hydrochloride
Application: 17/254,982 →
Publication: US 2021/0267944
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 62/876,371 →
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 62/877,056 →
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 62/963,769 →
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 62/970,411 →
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 62/977,554 →
Film Formulations Containing Dexmedetomidine and Methods of Producing Them
Application: 63/037,759 →
Non-Sedating Dexmedetomidine Treatment Regimens
Application: 62/943,022 →
Non-Sedating Dexmedetomidine Treatment Regimens
Application: 17/628,021 →
Publication: US 2024/0024288
Treatment of Mania and Psychosis Using Dexmedetomidine Hydrochloride
Application: 63/089,135 →
Dexmedetomidine Treatment Regimens
Application: 63/133,593 →
Dexmedetomidine Treatment Regimens
Application: 63/156,703 →
Dexmedetomidine Treatment Regimens
Application: 63/168,995 →
Dexmedetomidine Treatment Regimens
Application: 63/180,284 →
Dexmedetomidine Treatment Regimens
Application: 63/218,965 →
Dexmedetomidine Treatment Regimens
Application: 17/568,474 →
Publication: US 2022/0226288
Methods and Compositions for Treating Agitation
Application: 63/154,281 →
Methods for Treating Depressive States
Application: 63/218,031 →
Methods for Treating Depressive States
Application: 63/247,122 →
Prevention or Treatment of Sleep Disorders Using Dexmedetomidine Formulation
Use of Sublingual Dexmedetomidine for the Treatment of Agitation
Systems and Methods for Detection and Prevention of Emergence of Agitation
Systems and Methods for Detection and Prevention of Emergence of Agitation
Non-Sedating Dexmedetomidine Treatment Regimens
Treatment of Bipolar Disorders and Psychosis Using Dexmedetomidine Hydrochloride
Dexmedetomidine Treatment Regimens
Methods and Compositions for Treating Agitation
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 23, 2017
From: NANDABALAN, KRISHNAN; YOCCA, FRANK
To: BIOXCEL CORPORATION
Reel/Frame 042478/0060 →
Assignment of Assignor's Interest Jul 7, 2017
From: NANDABALAN, KRISHNAN; YOCCA, FRANK
To: BIOXCEL CORPORATION
Reel/Frame 043115/0266 →
Assignment of Assignor's Interest Jul 7, 2017
From: NANDABALAN, KRISHNAN; YOCCA, FRANK
To: BIOXCEL CORPORATION
Reel/Frame 042928/0931 →
Assignment of Assignor's Interest Oct 25, 2017
From: NANDABALAN, KRISHNAN; YOCCA, FRANK
To: BIOXCEL CORPORATION
Reel/Frame 044604/0477 →
Assignment of Assignor's Interest Nov 8, 2017
From: NEGI, HARSH; SAINI, DEEPA; SHARMA, SAMEER; NANDABALAN, KRISHNAN
To: BIOXCEL CORPORATION
Reel/Frame 044076/0058 →
Assignment of Assignor's Interest Nov 17, 2017
From: BIOXCEL CORPORATION
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 044482/0489 →
Assignment of Assignor's Interest Aug 12, 2019
From: HANLEY, DAVID CHRISTIAN; YOCCA, FRANK; LATHIA, CHETAN DALPATBHAI
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 050021/0123 →
Assignment of Assignor's Interest Aug 12, 2019
From: KAKUMANU, VASUKUMAR
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 050021/0151 →
Assignment of Assignor's Interest Aug 12, 2019
From: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 050021/0158 →
Assignment of Assignor's Interest Aug 12, 2019
From: BARNHART, SCOTT DAVID
To: ARX, LLC
Reel/Frame 050021/0186 →
Assignment of Assignor's Interest Aug 26, 2019
From: YOCCA, FRANK; DEVIVO, MICHAEL
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 050165/0876 →
Assignment of Assignor's Interest Nov 11, 2019
From: SHARMA, SAMEER
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 050970/0327 →
Assignment of Assignor's Interest Nov 11, 2019
From: E. Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 050970/0333 →
Assignment of Assignor's Interest Nov 11, 2019
From: NANDABALAN, KRISHNAN
To: BIOXCEL CORPORATION
Reel/Frame 050970/0190 →
Assignment of Assignor's Interest Nov 11, 2019
From: BIOXCEL CORPORATION
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 050970/0209 →
Assignment of Assignor's Interest Nov 11, 2019
From: YOCCA, FRANK
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 050970/0177 →
Assignment of Assignor's Interest Jul 17, 2020
From: BARNHART, SCOTT DAVID
To: ARX, LLC
Reel/Frame 053242/0257 →
Assignment of Assignor's Interest Jul 17, 2020
From: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 053242/0808 →
Assignment of Assignor's Interest Jul 17, 2020
From: HANLEY, DAVID CHRISTIAN; YOCCA, FRANK; LATHIA, CHETAN DALPATBHAI
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 053242/0187 →
Assignment of Assignor's Interest Jul 17, 2020
From: KAKUMANU, VASUKUMAR
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 053242/0768 →
Assignment of Assignor's Interest Nov 24, 2020
From: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 054460/0414 →
Assignment of Assignor's Interest Nov 24, 2020
From: BARNHART, SCOTT DAVID
To: ARX, LLC
Reel/Frame 054460/0460 →
Assignment of Assignor's Interest Nov 24, 2020
From: HANLEY, DAVID CHRISTIAN; YOCCA, FRANK; LATHIA, CHETAN DALPATBHAI
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 054460/0332 →
Assignment of Assignor's Interest Nov 24, 2020
From: KAKUMANU, VASUKUMAR
To: E.Z. BIOXCEL SOLUTIONS PVT. LTD.
Reel/Frame 054514/0629 →
Assignment of Assignor's Interest Dec 22, 2020
From: YOCCA, FRANK D.; DE VIVO, MICHAEL
To: BIOXCEL THERAPEUTICS, INC.
Reel/Frame 054721/0124 →